Arcadia Biosciences (RKDA) Change in Accured Expenses (2014 - 2025)

Arcadia Biosciences (RKDA) has 12 years of Change in Accured Expenses data on file, last reported at -$342000.0 in Q4 2025.

• Quarterly Change in Accured Expenses fell 3209.09% year-over-year to -$342000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$399000.0 (changed N/A YoY) and the FY2025 annual result came in at -$399000.0, changed N/A from the prior year.
• Change in Accured Expenses eased to -$342000.0 in Q4 2025, from $156000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $601000.0 in Q3 2024 to a low of -$678000.0 in Q1 2024.
• A 5-year average of -$120588.2 and a median of -$49000.0 in 2022 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 6700.0% — and 2024, when it jumped 292.63%.
• Tracing RKDA's Change in Accured Expenses over 5 years: stood at -$373000.0 in 2021, then surged by 135.66% to $133000.0 in 2022, then tumbled by 266.92% to -$222000.0 in 2023, then soared by 104.95% to $11000.0 in 2024, then tumbled by 3209.09% to -$342000.0 in 2025.
• The last three Change in Accured Expenses figures came in at -$342000.0 (Q4 2025), $156000.0 (Q2 2025), and -$213000.0 (Q1 2025), per Business Quant data.